This evidence further substantiated the opposite effects of EFNA4 and ETS1 in the context of tumour immunity, playing an important role in immune cell-related pathways, and suggesting that they may affect the progression of GC through T cell exhaustion. The gene discussed is ETS1; the disease is neoplasm.